Top 10 Books about Stock Investing to read in 2018. Read more.

IOVA - Iovance Biotherapeutics, Inc.

Fri 23'rd Feb 2018

PERIOD 2017-11-24 - 2018-02-23
CHANGE 2.70%
PRICE $19.00
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Request Prediction
0.00%
Predict

Iovance Biotherapeutics, Inc. Stock Analysis

Technical stock analysis for Fri 23'rd Feb 2018

Shorts 3.26% ( 2018-01-31 )
Cash 606.1 mill
Loans n/a
Beta 1.92
ROA -44.95
Buy candidate since 2018-01-10 Gain 120.93%

Iovance Biotherapeutics, Inc. gained 2.70% in the last trading day, rising from $18.50 to $19.00 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 6 of the last 10 days and is up by 15.5% over the past 2 weeks. Volume fell in the last day by -0.45 million shares, and in total, 2.18 million shares bought and sold for approximately $41.47 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Access today's Top 5 Strong Buy Candidates

Trend

Iovance Biotherapeutics, Inc. lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $19.21 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 138.76% during the next 3 months and, with 90% probability hold a price between $35.27 and $45.87 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Iovance Biotherapeutics, Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $17.88 and $13.78. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday February 20, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 74 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Iovance Biotherapeutics, Inc. finds support from accumulated volume at $18.50. There is no resistance from accumulated volume above today's level and given the right condition the stock may perform very well during the next couple of days.

Support: $18.50 Price: $19.00

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.85 between high and low, or 17.54%. For the last week, the stock has had a daily average volatility of 8.46%.

The stock is overbought on RSI14 and lies in the upper part of the trend. Normally this will pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stoploss: $18.26 (-3.92%) (This stock has high daily movements and this gives high risk. The RSI14 is 74 and this increases the risk substantially. There is a buy signal from pivot bottom found 3 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Iovance Biotherapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Trade IOVA CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL